Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, Jing Xie, Mark Sidhom, Abhijit Pal, Peter Grimison, Alison Y. Zhang, Siobhan Ng, Colin Tang, Elizabeth Hovey, Colin Chen, George Hruby, Alexander Guminski, Margaret McJannett, Ciara Conduit, Ben Tran, Ian D. Davis, Dickon Hayne
Topics & Concepts
MedicinePembrolizumabBladder cancerClinical endpointUrologyInternal medicineAdverse effectOncologyPhases of clinical researchResponse Evaluation Criteria in Solid TumorsSurgeryCancerClinical trialImmunotherapyBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis